new_0222_0731|DNA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0731|DNA|1|Ginkgo Bioworks Holdings Inc Total Current Assets (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Cash and Short Term Investments (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Inventories (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Net PP&E (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Goodwill and Intangibles (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Liabilities (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Current Liabilities (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Long Term Liabilities (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Deposits (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Book Value (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Retained Earnings (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Treasury Stock (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc EV to Revenues|Ginkgo Bioworks Holdings Inc EV to Earnings|Ginkgo Bioworks Holdings Inc EV to Free Cash Flow|Ginkgo Bioworks Holdings Inc EV to Assets (Quarterly)|Ginkgo Bioworks Holdings Inc PS Ratio|Ginkgo Bioworks Holdings Inc PE Ratio|Ginkgo Bioworks Holdings Inc Price to Book Value|Ginkgo Bioworks Holdings Inc PEG Ratio|Ginkgo Bioworks Holdings Inc Debt to Equity Ratio|Ginkgo Bioworks Holdings Inc Dividend Yield|Ginkgo Bioworks Holdings Inc Shareholder Yield (TTM)|Ginkgo Bioworks Holdings Inc Percent of Shares Outstanding Short|Ginkgo Bioworks Holdings Inc Total Receivables (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Payables (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Total Capital Stock (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Return on Invested Capital|Ginkgo Bioworks Holdings Inc Quality Ratio Score|Ginkgo Bioworks Holdings Inc Momentum Score|Ginkgo Bioworks Holdings Inc Beta (1Y)|Ginkgo Bioworks Holdings Inc Sustainable Growth Rate (TTM)|Ginkgo Bioworks Holdings Inc Institutional Investor Ownership Percentage|Ginkgo Bioworks Holdings Inc Average Diluted Shares Outstanding (Quarterly)|Ginkgo Bioworks Holdings Inc Total Employees (Annual)|Ginkgo Bioworks Holdings Inc EPS Diluted (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Shares Outstanding|Ginkgo Bioworks Holdings Inc Repurchase of Capital Stock (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Ordinary Shares Number (Quarterly)|Ginkgo Bioworks Holdings Inc Payout Ratio|Ginkgo Bioworks Holdings Inc Quick Ratio (Quarterly)|Ginkgo Bioworks Holdings Inc Normalized Diluted EPS (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Stock Buybacks (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Effective Tax Rate (TTM)|Ginkgo Bioworks Holdings Inc Return on Equity|Ginkgo Bioworks Holdings Inc Net Income (TTM) (USD)|Ginkgo Bioworks Holdings Inc Revenue (TTM) (USD)|Ginkgo Bioworks Holdings Inc Dividend Per Share (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Revenue (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Gross Profit (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc SG&A Expense (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Pre-Tax Income (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Net Income (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Net Interest Income (Quarterly) (USD)|Ginkgo Bioworks Holdings Inc Price (USD)|Ginkgo Bioworks Holdings Inc Total Return Price (USD)|Ginkgo Bioworks Holdings Inc Enterprise Value (USD)|Ginkgo Bioworks Holdings Inc 30-Day Average Daily Volume|Ginkgo Bioworks Holdings Inc 1 Year Price Returns (Daily)||
new_0222_0731|DNA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0731|DNA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|yearly|quarterly|yearly|monthly|yearly|quarterly|quarterly|quarterly|yearly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|yearly|yearly|yearly|yearly|yearly|yearly|daily|daily|daily|daily|quarterly||
new_0222_0731|DNA|5|||||||||||||||||||1.4387755102|||1.43396226415||15.375|||||||||30.75|365||365|26|365||||365|365||||||365|365|365|365|365|365|1.43192488263|1.43192488263|1.44329896907|1.44808743169|||
new_0222_0731|DNA|6|||||||||||||||||||98|||212||8|||||||||4|1||1|2|1||||1|1||||||1|1|1|1|1|1|213|213|97|183|||
new_0222_0731|DNA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0731|DNA|202009||||||||||||||||||||||||||||||||||1485.0612||-0.0175||||||-0.0175|||||||13.302|11.533|9.876|-26.12|-26.055|2.726|||||||
new_0222_0731|DNA|202103|||||||||||||||||||||||||||||||||||||||||||||||||||||||10.24|10.24||2921011.7333||9.87|
new_0222_0731|DNA|202106|||||||||||||||||||||||||||||||||||||||||||||||||||||||9.96|9.96||2065526.5333||9.87|9.97
new_0222_0731|DNA|202109|1810.569|1739.056|3.474|142.704|39.228|532.62|90.305|442.315||1551.551|-697.269|||||7.2345|||11.1057|||||0.6979|50.725|7.102|0.148||||||53.8017|1323.5741||-0.08|1486.7129|-24.998|1486.7129||19.8193|-0.0567|24.998||||||77.61|55.308|28.959|-102.612|-101.881|-0.528|11.59|11.59|15558.3665|6619342.7667||13.82|11.87
new_0222_0731|DNA|202112|||||||||||||||||||7.9628|||||3.3043|||||||||51.9887||||||||||||||||||||||8.31|8.31|10682.126|9717813.2667||5.98|4.665